Prof. Matthis Synofzik, head of the section “Translational Genomics of Neurodegenerative Diseases” at the HIH, speaks in an interview with Deutschlandfunk about individually tailored RNA therapies for extremely rare hereditary diseases and about the research program "One mutation - one medicine"